JP2008540513A - スキンケアのための組成物及び方法 - Google Patents
スキンケアのための組成物及び方法 Download PDFInfo
- Publication number
- JP2008540513A JP2008540513A JP2008510723A JP2008510723A JP2008540513A JP 2008540513 A JP2008540513 A JP 2008540513A JP 2008510723 A JP2008510723 A JP 2008510723A JP 2008510723 A JP2008510723 A JP 2008510723A JP 2008540513 A JP2008540513 A JP 2008540513A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- nicotinamide
- skin
- cadpr
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67932905P | 2005-05-10 | 2005-05-10 | |
| PCT/IL2006/000552 WO2006120681A2 (en) | 2005-05-10 | 2006-05-10 | Compositions and methods for skin care |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008540513A true JP2008540513A (ja) | 2008-11-20 |
| JP2008540513A5 JP2008540513A5 (https=) | 2009-06-18 |
Family
ID=37396969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008510723A Pending JP2008540513A (ja) | 2005-05-10 | 2006-05-10 | スキンケアのための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8034788B2 (https=) |
| EP (1) | EP1879449A4 (https=) |
| JP (1) | JP2008540513A (https=) |
| CN (1) | CN101217868A (https=) |
| AU (1) | AU2006245282A1 (https=) |
| CA (1) | CA2608021A1 (https=) |
| WO (1) | WO2006120681A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090098065A1 (en) * | 2000-01-11 | 2009-04-16 | Avikam Harel | Composition and methods for the treatment of skin disorders |
| US9173835B2 (en) | 2005-05-10 | 2015-11-03 | Dermipsor Ltd. | Compositions and methods for treating hyperproliferative epidermal diseases |
| WO2008131256A1 (en) * | 2007-04-19 | 2008-10-30 | Trinity Laboratories Inc. | Improved treatments for premature ejaculation in humans |
| WO2009022338A2 (en) * | 2007-08-16 | 2009-02-19 | Saher Hamed | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| FR2925313A1 (fr) * | 2007-12-19 | 2009-06-26 | Oreal | Utilisation cosmetique de proteines de type plakoglobine |
| FR2925314B1 (fr) * | 2007-12-19 | 2012-11-23 | Oreal | Utilisation cosmetique de proteines de type transglutaminase 3 |
| FR2936421B1 (fr) * | 2008-09-29 | 2011-02-11 | Bouill Mariya Le | Produit de beaute et de soin pour faire disparaitre les rides du visage, empecher leur apparition et maintenir la tonicite de la peau |
| RU2397770C1 (ru) * | 2008-12-30 | 2010-08-27 | Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" | Поливитаминная мазь для смягчения, питания и заживления кожи и способ ее получения |
| CN106265695B (zh) * | 2009-08-14 | 2021-05-07 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
| US20120322776A1 (en) * | 2009-12-22 | 2012-12-20 | Leo Pharma A/S | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
| WO2011087525A1 (en) * | 2010-01-17 | 2011-07-21 | The Procter & Gamble Company | Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population |
| KR102114892B1 (ko) * | 2016-01-11 | 2020-05-26 | 더 프록터 앤드 갬블 캄파니 | 피부 상태의 치료 방법 및 그를 위한 조성물 |
| AU2018216043B2 (en) * | 2017-02-06 | 2020-02-27 | 3Skin As | Sunscreen composition |
| KR102069088B1 (ko) * | 2018-04-02 | 2020-01-22 | 양미경 | 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물 |
| KR20210011964A (ko) | 2018-07-03 | 2021-02-02 | 더 프록터 앤드 갬블 캄파니 | 피부 병태를 치료하는 방법 |
| MX2021014028A (es) * | 2019-05-17 | 2022-02-21 | Univ Pennsylvania | Métodos y composiciones para tratar obesidad y/o trastornos de la piel. |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN115843238B (zh) | 2020-06-01 | 2025-06-10 | 宝洁公司 | 改善维生素b3化合物渗透到皮肤中的方法 |
| CN118384058A (zh) * | 2024-04-08 | 2024-07-26 | 云南贝泰妮生物科技集团股份有限公司 | 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001051051A2 (en) * | 2000-01-11 | 2001-07-19 | Avikam Harel | AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS |
| JP2002527356A (ja) * | 1998-07-16 | 2002-08-27 | ジェントリックス・リミテッド・ライアビリティ・カンパニー | 異常細胞増殖処置のための組成物および方法 |
| WO2004006887A2 (en) * | 2002-07-11 | 2004-01-22 | Dermipsor Ltd. | Composition and methods for the treatment of skin disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120722A (en) * | 1984-02-08 | 1992-06-09 | Hoffmann-La Roche Inc. | Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia |
| JPH07100685B2 (ja) * | 1985-08-02 | 1995-11-01 | レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ/エス(レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ) | 新規ビタミンd類似体 |
| US5145846A (en) * | 1988-01-20 | 1992-09-08 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
| US4851401A (en) * | 1988-07-14 | 1989-07-25 | Wisconsin Alumni Research Foundation | Novel cyclopentano-vitamin D analogs |
| CA1333616C (en) | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
| GB9007236D0 (en) | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| ATE143007T1 (de) * | 1991-07-05 | 1996-10-15 | Duphar Int Res | Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür |
| DE4141746A1 (de) * | 1991-12-13 | 1993-06-17 | Schering Ag | 20-methyl-substituierte vitamin d-derivate |
| US5237629A (en) * | 1992-03-19 | 1993-08-17 | The United States Of America As Represented By The United States Department Of Energy | Digitally controlled distributed phase shifter |
| GB9206648D0 (en) * | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US5747479A (en) * | 1996-01-03 | 1998-05-05 | Hoffmann-La Roche Inc. | Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin |
| IL126802A0 (en) * | 1996-05-02 | 1999-08-17 | Duphar Int Res | Vitamin d analogs and methods of preparing these compounds |
| US5811414A (en) * | 1997-05-16 | 1998-09-22 | Hoffmann-La Roche Inc. | Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin |
| US6262041B1 (en) * | 1998-04-06 | 2001-07-17 | Bertek Pharmaceuticals, Inc. | Use of vitamin D analogs to treat conditions related to increased oxidative stress |
| US6552009B2 (en) * | 1998-07-16 | 2003-04-22 | Gentrix Llc | Compositions and methods of treating abnormal cell proliferation |
| US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
| PT3146969T (pt) * | 1999-04-23 | 2018-10-18 | Leo Pharma As | Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide |
| FR2801305B1 (fr) * | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
-
2006
- 2006-05-10 WO PCT/IL2006/000552 patent/WO2006120681A2/en not_active Ceased
- 2006-05-10 JP JP2008510723A patent/JP2008540513A/ja active Pending
- 2006-05-10 CA CA002608021A patent/CA2608021A1/en not_active Abandoned
- 2006-05-10 US US11/914,093 patent/US8034788B2/en not_active Expired - Fee Related
- 2006-05-10 AU AU2006245282A patent/AU2006245282A1/en not_active Abandoned
- 2006-05-10 CN CNA2006800220611A patent/CN101217868A/zh active Pending
- 2006-05-10 EP EP06728341A patent/EP1879449A4/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002527356A (ja) * | 1998-07-16 | 2002-08-27 | ジェントリックス・リミテッド・ライアビリティ・カンパニー | 異常細胞増殖処置のための組成物および方法 |
| WO2001051051A2 (en) * | 2000-01-11 | 2001-07-19 | Avikam Harel | AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS |
| WO2004006887A2 (en) * | 2002-07-11 | 2004-01-22 | Dermipsor Ltd. | Composition and methods for the treatment of skin disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1879449A2 (en) | 2008-01-23 |
| CA2608021A1 (en) | 2006-11-16 |
| EP1879449A4 (en) | 2009-12-16 |
| US20080312181A1 (en) | 2008-12-18 |
| US8034788B2 (en) | 2011-10-11 |
| CN101217868A (zh) | 2008-07-09 |
| WO2006120681A3 (en) | 2007-01-25 |
| WO2006120681A2 (en) | 2006-11-16 |
| AU2006245282A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8034788B2 (en) | Composition and methods for skin care | |
| JP3802034B2 (ja) | ベツリン酸を含む化粧品組成物 | |
| US5621008A (en) | N-acyl-ethylene-triacetic acids | |
| RU2562140C2 (ru) | Композиция и способ для лечения признаков старения кожи | |
| KR20080012339A (ko) | 과증식성 상피 질환 치료 조성물 및 방법 | |
| US20160175223A1 (en) | Anti-aging compositions comprising bile acid-fatty acid conjugates | |
| KR20150143698A (ko) | 항산화제 조성물 및 이의 사용 방법 | |
| EP3030229B1 (en) | Anti-acne compositions comprising bile acid-fatty acid conjugates | |
| AU658461B2 (en) | Skin care composition | |
| JP2005507882A (ja) | 皮膚不調の治療方法 | |
| JP3792651B2 (ja) | 二重区画包装においてレチノイド、レチノイドブースター、およびフィトエストロゲンを含んでいるスキンケア製品 | |
| DE60124307T2 (de) | Hautpflegemittel enthaltend retinoide und phytoöstrogene in einem doppelkammer-behältnis | |
| US20050197407A1 (en) | Method and preparation for reducing irritation and/or inflammatory reaction in human skin | |
| HK1003028B (en) | Skin care composition | |
| US20140037561A1 (en) | Composition and methods of enhanced skin cell turnover | |
| JP2007284430A (ja) | グルタチオン産生促進剤 | |
| ES2356939T3 (es) | Composiciones que contienen retinoide y derivados de cromenona. | |
| IL187237A (en) | Preparations containing calcipotriol and nicotinamide for use in skin care | |
| US20240423897A1 (en) | Longevity serum | |
| US20240423899A1 (en) | Longevity moisturizing cream | |
| JPH11246389A (ja) | 美白用化粧組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090427 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090427 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120207 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120420 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120427 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121005 |